Associate Director, Clinical Project Scientist
Johnson & Johnson
Fouad Moussa a is an Associate Director in Clinical Sciences at Johnson & Johnson Innovative Medicine and currently serves as the Study Responsible Scientist for the Phase 3 KLK2-comPAS study. He earned his PhD from Kent State University and completed postdoctoral fellowship training at the Children’s Hospital of Philadelphia. Following fellowship, he joined Abzyme Therapeutics as a scientist, where he worked on bispecific antibodies development. Fouad joined Johnson & Johnson in 2020 and has contributed to several key oncology programs in Discovery and Clinical, including PSMAxCD3 and Pasritamig combination treatments.